Books
Caroff SN, Mann SC, Francis A & Fricchione GL (Eds.). (2004) Catatonia: from psychopathology to neurobiology. Washington, D.C.: American Psychiatric Publishing
Fink M, Taylor MA (2003). Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge, UK:Cambridge University Press
Papers
General Adult Catatonia (Reviews)
Fink M: Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand 2013; 127(Suppl. 441):1–47
Northoff G: What catatonia can tell us about “top down modulation”: a neuropsychiatric hypothesis. Behavior and Brain Sciences 2002; 25:555-604
Carroll BT, Goforth HW, Thomas C, Ahuja N, McDaniel WW, Kraus MF, Spiegel DR, Franco KN, Pozuelo L, Muñoz C: Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007; 19(4):406-412
Fricchione G, Bush G, Fozdar M, Francis A, Fink M: Recognition and treatment of the catatonic syndrome. J Intensive Care Med 1887; 12:135-147
CD-AMC
Carroll BT, Mendenhall B, Appiani F, Spiegel D, McDaniel W: Catatonia due to a general medical condition (organic catatonia). Current Psychiatry Reviews 2013; 9(2):106-110
Duggal HS, Singh I: Drug-induced catatonia. Drugs Today (Barc) 2005; 41(9):599-607
Rating Scales
Sienaert P, Rooseleer J, De Fruyt J: Measuring catatonia: a systematic review of rating scales. J Affect Disord 201; 135:1-9
Bush G, Fink M, Petrides G et al: Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136
Pediatric Catatonia
Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, Sedel F, An-Gourfinkel I, Bonnot O, Cohen D: Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res 2012; 137:151-158
Ghaziuddin N, Dhossche D, Marcotte K: Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand 2012; 125(1):33-38
Raffin M, Zugaj-Bensaou L, Bodeau N, Milhiet V, Laurent C, Cohen D, Consoli A: Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry 2014 Aug 27. [Epub ahead of print]
Catatonia in Autism
Ohta M, Kano Y, Nagai Y: Catatonia in individuals with autism spectrum disorders in adolescence and early adulthood: a long-term prospective study. Int Rev Neurobiol. 2006; 72:41-54
Mazzone L, Postorino V, Valeri G, Vicari S: Catatonia in patients with autism: prevalence and management. CNS Drugs 2014; 28(3):205-15
Malignant Catatonia/NMS
Strawn JR, Keck PE Jr, Caroff SN: Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164(6):870-876
Neuhut R, Lindenmayer JP, Silva R: Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review. J Child Adolesc Psychopharmacol 2009; 19(4):415-422
Mann SC, Caroff SN, Ungvari GS, Campbell EC: Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome. Curr Psychiatry Rev 2013; 9:111-119
Anti-NMDA-receptor Encephalitis
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63-74
DeSena AD, Greenberg BM, Graves D: Three phenotypes of anti-n-methyl-d-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis. Pediatr Neurol 2014; 51(4):542-549
